Equity

Quarterly ResultsHome > Equity > Corporate Information > Quarterly Results

Jubilant Pharmova LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code:530019 NSE Symbol: JUBLPHARMA P/E (TTM) :0
ISIN Demat:INE700A01033 Div & Yield %:0.73 EPS (TTM) :0
Book Value (RS) :146.9008161 Market Cap (Rs Cr.):10933.56 Face Value (RS) :1
    Change Company 
Quarters :  
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
 (Rs in Cr)(Rs in Cr)(Rs in Cr)(Rs in Cr)
Gross Sales 170.20179.40203.90189.40
Other Operating Income 5.006.9013.5010.40
Other Income  19.0018.4015.9013.70
Total Income 194.20204.70233.30213.50
Total Expenditure  175.90185.50213.20197.70
PBIDT 18.3019.2020.1015.80
Interest  8.307.106.405.70
PBDT 10.0012.1013.7010.10
Depreciation 12.3011.9011.4011.30
Tax -0.400.000.40-0.60
Fringe Benefit Tax 0.000.000.000.00
Deferred Tax 0.500.600.0030.20
Reported Profit After Tax -2.40-0.401.90-30.80
Extra-ordinary Items  0.000.000.000.00
Adjusted Profit After Extra-ordinary item -2.40-0.401.90-30.80
     
EPS (Unit Curr.) -0.15-0.030.12-1.94
EPS (Adj) (Unit Curr.) -0.15-0.030.12-1.94
Calculated EPS (Unit Curr.) -0.15-0.030.12-1.94
Calculated EPS (Adj) (Unit Curr.) -0.15-0.030.12-1.94
Calculated EPS (Ann.) (Unit Curr.) -0.60-0.100.48-7.75
Calculated EPS (Adj) (Ann.) (Unit Curr.) -0.60-0.100.48-7.75
Book Value (Unit Curr.) 0.000.000.000.00
Dividend (%) 0.000.000.000.00
Equity 15.9015.9015.9015.90
Reserve & Surplus 0.000.000.000.00
Face Value 1.001.001.001.00
     
Public Shareholding (No. Of Shares) 0.000.000.000.00
Public Shareholding (% in Equity) 0.000.000.000.00
     
Pledged/Encumbered - No. of Shares 0.000.000.000.00
Pledged/Encumbered - % in Total Promoters Holding 0.000.000.000.00
Pledged/Encumbered - % in Total Equity 0.000.000.000.00
     
Non Encumbered - No. of Shares 0.000.000.000.00
Non Encumbered - % in Total Promoters Holding 0.000.000.000.00
Non Encumbered - % in Total Equity 0.000.000.000.00
     
PBIDTM(%) 10.7510.709.868.34
PBDTM(%) 5.886.746.725.33
PATM(%) -1.41-0.220.93-16.26

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)